These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6286121)

  • 1. Platinum concentrations in human glioblastoma multiforme following the use of cisplatin.
    Bonnem EM; Litterst CL; Smith FP
    Cancer Treat Rep; 1982 Aug; 66(8):1661-3. PubMed ID: 6286121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.
    Grunnet ML; O'Neill A; Gilbert M; Hellman R
    Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug cocktails for effective treatment of glioblastoma multiforme.
    Debinski W
    Expert Rev Neurother; 2008 Apr; 8(4):515-7. PubMed ID: 18416653
    [No Abstract]   [Full Text] [Related]  

  • 6. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours.
    Koukourakis MI; Koukouraki S; Fezoulidis I; Kelekis N; Kyrias G; Archimandritis S; Karkavitsas N
    Br J Cancer; 2000 Nov; 83(10):1281-6. PubMed ID: 11044350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors.
    Stewart DJ; Leavens M; Maor M; Feun L; Luna M; Bonura J; Caprioli R; Loo TL; Benjamin RS
    Cancer Res; 1982 Jun; 42(6):2474-9. PubMed ID: 6280860
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
    Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
    Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394.
    Grossman SA; O'Neill A; Grunnet M; Mehta M; Pearlman JL; Wagner H; Gilbert M; Newton HB; Hellman R;
    J Clin Oncol; 2003 Apr; 21(8):1485-91. PubMed ID: 12697871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of beta-amyloid precursor protein expression in glioblastoma multiforme.
    Culicchia F; Cui JG; Li YY; Lukiw WJ
    Neuroreport; 2008 Jun; 19(9):981-5. PubMed ID: 18521005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of methylglyoxal bis(guanylhydrazone) into intracerebral tumors in humans.
    Rosenblum MG; Stewart DJ; Yap BS; Leavens M; Benjamin RS; Loo TL
    Cancer Res; 1981 Feb; 41(2):459-62. PubMed ID: 7448791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.
    Ma Y; Yuan RQ; Fan S; Hu C; Goldberg ID; Laterra JJ; Rosen EM
    Anticancer Drugs; 2006 Aug; 17(7):733-51. PubMed ID: 16926624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical pharmacokinetics of carboplatin and MCNU in malignant brain tumor and normal brain tissues].
    Shinohara C; Matsumoto K; Kuriyama M; Adachi H; Ono Y; Higashi H; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1163-8. PubMed ID: 8031157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
    Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
    J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular and orbital complications of intraarterial cisplatin. A case report.
    Wu HM; Lee AG; Lehane DE; Chi TL; Lewis RA
    J Neuroophthalmol; 1997 Sep; 17(3):195-8. PubMed ID: 9304534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose tamoxifen treatment increases the incidence of multifocal tumor recurrences in glioblastoma patients.
    Puchner MJ; Giese A; Lohmann F; Cristante L
    Anticancer Res; 2004; 24(6):4195-203. PubMed ID: 15736473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-pi gene in human glioblastoma cells.
    Brandt TY; Ali-Osman F
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):22-9. PubMed ID: 9073588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.
    Joshi BH; Leland P; Asher A; Prayson RA; Varricchio F; Puri RK
    Cancer Res; 2001 Nov; 61(22):8058-61. PubMed ID: 11719427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the expression of endothelial-monocyte activating polypeptide II (EMAPII) in the treatment of glioblastoma with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Yamamoto M; Fukushima T; Ueno Y; Hayashi S; Kimura H; Soma G; Tomonaga M
    Anticancer Res; 2000; 20(6A):4081-6. PubMed ID: 11131676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.